(Total Views: 864)
Posted On: 11/11/2020 7:58:09 AM
Post# of 151044
FKAdam,
I would have your friends and colleagues read the talk market piece from last night. It does a good job of explaining both the HIV and covid regulatory situations for leronlimab.
https://talkmarkets.com/content/stocks--equit...ost=284999
I imagine at this point that your doubting colleagues are bailing due to share price pummeling in the face of remdesivir, Pfizer vaccine and the Lilly mAb.
A deep dive into science is unlikely to ease frayed nerves.
I would have your friends and colleagues read the talk market piece from last night. It does a good job of explaining both the HIV and covid regulatory situations for leronlimab.
https://talkmarkets.com/content/stocks--equit...ost=284999
I imagine at this point that your doubting colleagues are bailing due to share price pummeling in the face of remdesivir, Pfizer vaccine and the Lilly mAb.
A deep dive into science is unlikely to ease frayed nerves.
(9)
(0)Scroll down for more posts ▼
